Mediar Therapeutics的封面图片
Mediar Therapeutics

Mediar Therapeutics

生物技术研究

Boston,Massachusetts 3,345 位关注者

Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt fibrosis progression.

关于我们

Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure. Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach. For more information, contact [email protected]

网站
https://www.mediartx.com
所属行业
生物技术研究
规模
11-50 人
总部
Boston,Massachusetts
类型
私人持股
创立
2019

地点

  • 主要

    20 Overland St

    Suite 520

    US,Massachusetts,Boston,02215

    获取路线

Mediar Therapeutics员工

动态

  • Mediar Therapeutics转发了

    查看Aashna Gupta, SHRM-CP的档案

    Director, Head of Human Resources @ Mediar Therapeutics | SHRM-CP

    As HR, my job is to make sure everyone feels valued and appreciated… including myself. ???? Happy Employee Appreciation Day! Colleen Doyle, SHRM-CP and I sent out cupcakes to the Mediar Therapeutics team as a sweet token of appreciation, and—purely by coincidence, of course—some landed on our desks too. ????♀? A huge shoutout to our amazing employees who make every day better. #EmployeeAppreciationDay

    • 该图片无替代文字
  • In honor of International Women’s Day tomorrow, we wanted to take a moment to recognize the remarkable women who empower our community, push the boundaries of science with curiosity, and lead with unwavering integrity. Their contributions drive innovation, inspire progress, and shape the future of biotech. At Mediar, we are dedicated to fostering an inclusive and supportive environment where every voice is heard, valued, and uplifted. We acknowledge the essential role women play in advancing biotech and are proud to support equity, mentorship, and growth opportunities for women in STEM and beyond. Join us in celebrating the achievements of women across the globe and continuing the work toward a more inclusive future. #InternationalWomensDay #IWD2025 #WomenInSTEM #BiotechInnovation

    • 该图片无替代文字
  • Celebrating Milestones: March Work Anniversaries ?? At Mediar, we believe that our success is a direct reflection of the passion, dedication, and innovation of our team. ?We are proud to recognize and celebrate the work anniversaries of some exceptional team members this March. Join us in congratulating: Ben Wilks, PhD – Principal Scientist, Preclinical: 3 years Aashna Gupta, SHRM-CP – Director, Human Resources: 2 years Morgan Fetherolf, PhD – Principal Scientist, Antibody Engineering: 2 years Daniel Beal, RN, BSN, MBA – Director, Clinical Trial Lead: 1 year Thank you for all the passion, knowledge, and creativity you bring to our team every day. We look forward to achieving even more together in the years ahead!

    • 该图片无替代文字
  • 查看Mediar Therapeutics的组织主页

    3,345 位关注者

    On February 28, we join the global community in observing Rare Disease Day, a crucial initiative to raise awareness for the 300 million individuals worldwide living with rare diseases. As a clinical stage biotech company, we're committed to addressing the unique challenges faced by those affected by rare fibrotic conditions. Rare diseases often present complex hurdles: ? Limited treatment options ? Delayed diagnoses ? Insufficient research funding ? Isolation due to disease rarity Our innovative approach targets myofibroblasts, the key drivers of fibrosis, aiming to halt disease progression and prevent organ failure. We hope to develop transformative therapies for rare fibrotic disorders that currently lack effective treatments. Today, we honor the resilience of rare disease patients and their families. We reaffirm our dedication to advancing research and developing novel solutions that may one day improve the lives of those affected by these challenging conditions. #RareDiseaseDay2025 #FibrosisResearch #RareDisease #Biotech

    • 该图片无替代文字
  • Today, on National Caregivers Day, we recognize and honor the incredible individuals who provide unwavering care to those living with chronic conditions like late-stage fibrosis. Their compassion, dedication, and selflessness make a profound difference in the lives of patients and their families. At Mediar, we’re committed to advancing research and treatments that support patients and their caregivers in their journey. We understand that caregivers are often the unsung heroes, and we stand beside them as we work toward transformative solutions. To all caregivers: Your impact is immeasurable, and we thank you from the bottom of our hearts. #NationalCaregiversDay #BiotechInnovation

    • 该图片无替代文字
  • 查看Mediar Therapeutics的组织主页

    3,345 位关注者

    Today, we celebrate International Day of Women and Girls in Science, observed annually on February 11th. At Mediar, we recognize the crucial role women play in advancing scientific knowledge and innovation. As a clinical stage biotech company, we believe that diversity in research expands the pool of talented researchers, bringing fresh perspectives and creativity to tackle global challenges. Let's continue to inspire, influence, and involve women in science, breaking down barriers and building a more equitable future in STEM. Together, we can shape the future of healthcare and biotechnology through inclusive leadership and innovation. #WomenInScience #GirlsInSTEM #BiotechInnovation

    • 该图片无替代文字
  • 查看Mediar Therapeutics的组织主页

    3,345 位关注者

    Celebrating Our Team: February Work Anniversaries ?? At Mediar, our greatest asset is our people. This February, we are honoring some exceptional team members who have reached significant milestones with us. To make it extra special, we've asked their colleagues to share what makes each of these individuals truly remarkable. These quotes capture the spirit, dedication, and unique contributions each person brings to Mediar. Join us in congratulating: Rahul Ballal, PhD - CEO: 2-year anniversary Saroj Nepal, PhD - Senior Scientist, Translational Medicine: 5-year anniversary Christopher Littlefield - Associate Director, Translational Medicine: 2-year anniversary Wendy Kwan, CPA - VP, Finance: 2-year anniversary We're grateful for their commitment, expertise, and the positive impact they make every day. Here's to many more years of innovation and success together!

  • 查看Mediar Therapeutics的组织主页

    3,345 位关注者

    Welcoming New Talent: Strengthening Our Innovative Team We are thrilled to announce the latest additions to our dynamic clinical-stage biotech team! These exceptional professionals bring cutting-edge expertise and fresh perspectives that will accelerate our mission to develop groundbreaking medical solutions. Our new colleagues: Vicki Kolb – Director, Clinical Site Liaison Juan-Pablo Lopez-Zertuche Ortiz, MD – Associate Medical Director Quinn Parks – Director, Clinical Supply Chain Lead Amanda West, MPH – Associate Director, Data Management Welcome aboard! We can't wait to see the incredible contributions you'll make to our organization and the future of healthcare. #BiotechInnovation #NewHires #ScientificResearch #TeamGrowth

  • 查看Mediar Therapeutics的组织主页

    3,345 位关注者

    Happy Lunar New Year! In 2025, we're experiencing a remarkable event - the Year of the Wood Snake, a combination that emerges only once every 60 years. This isn't just another new year; it's a profound moment of strategic renewal and transformative potential. Just as the Snake symbolizes wisdom and renewal through its ability to shed its skin, we in life sciences are constantly evolving. To our colleagues, partners, and friends: May 2025 be a year of meaningful transformation, breakthrough innovations, and compassionate progress. Gong Xi Fa Cai! #LunarNewYear #Biotech #Innovation #Transformation

相似主页

查看职位

融资